Platform
Company
Endocrine & Reproductive
Review status
Currently under review
Pending specialist review and validation.
Anti-Mullerian Hormone is a protein made mainly by cells in the ovaries in women and by Sertoli cells in the testes in males. In adults with ovaries, AMH reflects the number of small developing follicles, often called ovarian reserve. In infants and children, especially males, AMH helps assess testicular presence and function.
AMH is measured in a blood sample. Levels tend to be relatively stable across the menstrual cycle compared with many other hormones, and they are influenced by age, reproductive biology, and certain medical conditions. Your clinician interprets AMH alongside your history and other tests.
For people with ovaries, AMH helps estimate ovarian reserve, guide fertility counseling, and inform decisions such as timing or dosing for assisted reproductive treatments. It can also provide context when periods are irregular and may support evaluation for conditions that affect ovarian function.
In infants, children, and adults with testes, AMH can help determine whether testicular tissue is present and functioning, which is useful in evaluating undescended testes and some differences of sex development. AMH is not a standalone measure of fertility potential or egg quality; it is one piece of a broader clinical picture that includes age, ultrasound findings, and other lab tests.
Your AMH result is interpreted using age- and sex-specific expectations, your medical history, and your goals, such as family planning. In people with ovaries, higher or lower values can suggest differences in the remaining pool of follicles, but AMH does not predict whether you will conceive or the health of future pregnancies. In people with testes, results help assess whether testes are present and producing hormones appropriate for age.
If your result is unexpected, your clinician may review medications, supplements, and timing, consider repeating the test, or order related tests like follicle-stimulating hormone, antral follicle count by ultrasound, estradiol, or semen analysis. Because assays differ between laboratories, trends are best followed using the same method when possible.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
AMH naturally changes with age and differs between people with ovaries and those with testes. Interpretation always accounts for age and sex, especially in children and around reproductive milestones.
Combined oral contraceptives and pregnancy can lower measured AMH temporarily. Levels may rebound after stopping contraception or after pregnancy, so timing can affect interpretation.
Polycystic ovary syndrome, prior ovarian surgery, chemotherapy, radiation, endometriosis, and ovarian cysts can influence AMH. In males, anorchia or undescended testes can be reflected in AMH patterns.
Different laboratory methods can yield slightly different results. High-dose biotin and heterophile antibodies can interfere with some immunoassays, so tell your clinician about supplements before testing.
Hemolysis, delayed processing, or extreme storage conditions can affect measurements. Although AMH varies less by time of day, using the same lab and conditions helps with reliable comparisons.
References